Despite strong growth forecasts, Oncology Institute's low P/...
Despite strong growth forecasts, Oncology Institute's low P/S ratio suggests shareholding doubts. Investors' optimism tests the P/S ratio due to potential risks, leading to future performance speculation.
![](https://pubimg-10000538.picsh.myqcloud.com/2022050900000245dfe0ca97768.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment